Background/Aims: Our recent study indicated that the serum microcystin-LR (MC-LR) level is positively linked to the risk of human hepatocellular carcinoma (HCC). Gankyrin is overexpressed in cancers and mediates oncogenesis; however, whether MC-LR induces tumor formation and the role of gankyrin in this process is unclear. Methods: We induced malignant transformation of L02 liver cells via 35 passages with exposure to 1, 10, or 100 nM MC-LR. Wound healing, plate and soft agar colony counts, and nude mice tumor formation were used to evaluate the tumorigenic phenotype of MC-LR-treated cells. Silencing gankyrin was used to confirm its function. We established a 35-week MC-LR exposure rat model by twice weekly intraperitoneal injection with 10 μg/kg body weight. In addition, 96 HCC patients were tested for tumor tissue gankyrin expression and serum MC-LR levels. Results: Chronic low-dose MC-LR exposure increased proliferation, mobility, clone and tumor formation abilities of L02 cells as a result of gankyrin activation, while silencing gankyrin inhibited the carcinogenic phenotype of MC-LR-treated cells. MC-LR also induced neoplastic liver lesions in Sprague-Dawley rats due to up-regulated gankyrin. Furthermore, a trend of increased gankyrin was observed in humans exposed to MC-LR. Conclusion: These results suggest that MC-LR induces hepatocarcinogenesis in vitro and in vivo by increasing gankyrin levels, providing new insight into MC-LR carcinogenicity studies.
cyanobacterial toxin, induces cytotoxicity and tumor promotion mainly by increasing ROS formation and inhibiting PP1 and PP2A (serine/threonine protein phosphatases 1 and 2A), leading to hyperphosphorylation of several proteins involved in maintaining cell homeostasis [1] . MC-LR influences the structure and function of the liver, kidney, brain, testicle, and thyroid gland in animals [2] [3] [4] [5] [6] . In addition, we have previously reported that MC-LR impaired liver and kidney function in humans [7, 8] .
The main target organ of MC-LR is the liver, and several animal experiments have clearly demonstrated the tumor-promoting ability of MC-LR in this organ. However, controversy surrounds whether MC-LR can induce tumor formation. Although chronic low-dose MC-LR exposure did not increase the risk of developing tumors or induce tumors in animals [9] , some data has indicated its tumorigenicity in cell lines [10, 11] and our recent population study demonstrated a significant positive correlation between serum MC-LR levels and risk of hepatocellular carcinoma (HCC) [12] . Hence, the objective of this study was to elucidate the effects and mechanisms of MC-LR in tumor inducement in vitro and in vivo.
Gankyrin, a 26S proteasome non-ATPase regulatory subunit encoded by PSMD10, is dramatically increased in several cancers, including HCC [13, 14] . It is recognized as a key oncoprotein in the development of cancer due to its degradation effect on P53 [15, 16] . Gankyrin facilitates HCC development by mediating the de-differentiation of hepatocyte cells via HNF4α down-regulation [17] and accelerates liver cancer metastasis via activation of phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1 α pathways [18] . In addition, gankyrin promotes the malignant transformation of liver fibrosis to hepatocarcinoma via the Ras-related C3 botulinum toxin substrate 1/c-jun N-terminal kinase pathway [19] . Interfering with gankyrin expression may serve as a novel strategy for HCC prevention and treatment [20, 21] .
In this study, chronic MC-LR exposure induced the malignant transformation of L02 cells as a result of increased gankyrin levels. Then, by establishing a rat model through continuous exposure to MC-LR for 35 weeks, we confirmed the relationship between MC-LR and gankyrin in vivo. Furthermore, we analyzed the association of the internal exposure level of MC-LR and gankyrin expression in patients with HCC. Together, these results indicate that MC-LR can activate the oncogene gankyrin to induce malignant transformation, in addition to providing new information for intervention and carcinogenicity studies of MC-LR.
Materials and Methods

Cell treatment
We obtained the L02 cells from the Department of Hepatobiliary Surgery (Southwest Hospital of the Army Medical University, Chongqing, China). This cell line consists of normal human liver cell lines and is suitable to study the process of hepatocarcinogenesis from a normal to malignant state. Cells were continuously exposed to 0.1% DMSO (Sigma-Aldrich, St. Louis, MO, USA) as control cells or different doses (0, 1, 10, or 100 nM) of MC-LR (Express, Inc. Beijing, China) for 5, 15, 25, and 35 passages (named P5, P15, P25, and P35, respectively). The cells were cultured at 37°C and with 5% CO 2 on Dulbecco's modified Eagle media (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin.
Cell proliferation assay
Cells treated with MC-LR or DMSO were grown for 12, 24, 48, and 72 h in 96-well plates with 5000 cells per well at 37°C with 5% CO 2 . The cells were then incubated with 10 μl of Cell Counting Kit 8 (CCK-8) reagent (Dojindo, Japan) for 1 h and measured at an absorbance of 450 nm using a Multiskan MK3 instrument (Thermo Fisher Scientific, Waltham, MA, USA).
Scratch experiment
This procedure has been described previously [22] . Briefly, cells were cultured with DMEM containing 10% FBS and 1% penicillin-streptomycin at 37°C with 5% CO 2 . After the cells grew to 100% integration, a vertical wound was made in cells plated in 6-well plates using a sterilized 10-μl pipette tip. We then removed the detached cells using PBS and added medium. We observed the wound after 12 and 24 h at 20× magnification using a microscope and Image Pro Plus version 6.0 software to assess wound closure. Plate cloning analysis Cells (1 × 10 3 ) were cultured in 6-well plates for 15 days and the medium was changed every four days. Cells were fixed for 10 min with paraformaldehyde and then Giemsa-stained for 10 min. Visible cloning was observed and evaluated.
Soft agar assay
This method has been previously described [23] . Briefly, soft agar with two layers was prepared in each well of the 12-well plates. The base layer contained 1 ml of 1.3% agar, and 2 × 10 3 cells in medium containing 0.35% agar were plated above it and incubated at 37°C for 2 weeks. Colony formation (>0.5 mm in diameter) was counted using an inverted microscope at 20× magnification, and the total number of colonies on the entire plate was counted. The relative colony count was calculated using the colony count on each plate/cells plated.
BALB/c nude mice tumor formation
The Institutional Animal Care and Use Committee of the Army Medical University approved all animal treatments. We purchased BALB/c nude mice (aged 4 weeks, male) from the Experimental Animal Center of the Army Medical University. Each group contained three nude mice. Each mouse received 2 × 10 6 L02 cells for the control group and MC-LR-treated groups, which were injected into the left armpit of the mouse. Observations were made every two days for 28 days and the length and width of each tumor was measured.
Gene silencing and plasmid transfection MC-LR-treated L02 cells (100 nM) were transfected using Plve1761vctor lentiviral small interfering RNA (siRNA) particles (Sunbio Medical Biotechnology Co., Ltd, Shanghai, China) containing an siRNA sequence specific for gankyrin (AAGACACUGAGGGUAACACTT) or the control siRNA sequence (TTCTCCGAACGTGTCACGT) at 15 TU/cell. Cells were cultured with 10% FBS DMEM containing polybrene (2 µg/ml) for 1 h at 37°C. We selected cells expressing siRNAs using 4 µg/ml puromycin for 2 weeks. The interference efficiency of gankyrin was evaluated via quantitative real-time PCR (qRT-PCR) and western blot.
Animal model
Sprague-Dawley (SD) rats (aged 6 weeks, male) were obtained from the Army Medical University Experimental Animal Center and raised in a germ-free animal house. We randomly divided 54 SD rats into two groups, the control group and MC-LR-treated group (each group containing 27 rats). Rats were injected intraperitoneally twice a week with 2 mg DMSO/kg body weight (bw) for the control group and 10 µg/kg bw MC-LR for the MC-LR-treated group at 7 weeks of age and randomly euthanized after treatment for 10, 20, or 35 weeks. Liver sections were stained with hematoxylin and eosin (HE) or immunohistochemical (IHC) and the remaining tissues were stored at -80°C for subsequent analysis.
HCC patient tumor tissues and MC-LR exposure test
The Ethics Committee of the Army Medical University approved this study and all participants signed informed consent forms. We randomly selected 96 patients with HCC from our previous case-control study [12] . Liver tumor tissues were collected following surgery on patients diagnosed with HCC from Army Medical University hospitals. Serum MC-LR concentrations were measured using enzyme-linked immunosorbent assay kits (Beacon Analytical Systems, Inc., Saco, Maine, USA). The 96 participants were divided into two groups based on their median MC-LR exposure levels, termed the high-MC-LR exposure group and low-MC-LR exposure group.
qRT-PCR analysis
Total RNA was extracted using trizol (Sigma-Aldrich) according to the manufacturer's protocol. Two micrograms RNA was used for cDNA synthesis using the protocol of the RNA reverse transcription kit (Takara Bio, Inc., Otsu, Japan). Two microliters cDNA, 10 μl mix, 1 μl forward primer, 1 μl reverse primer, and 6 μl H 2 O 2 were mixed and underwent stage 1: one cycle of 95°C for 10 min; stage 2: 40 cycles of 95°C for 15 s and 60°C for 20 s; and stage 3: melt curve analysis. The reaction was performed using the SYBR Green PCR Kit (Takara Bio, Inc.) and an Applied Biosystems CXF-96 PCR instrument (Bio-rad, California, USA). The primers were purchased from the Shanghai Shenggong Company and the homo primers were: GAPDH forward: CACTCCTCTACACTTAGCCTGTGA, reverse: TAACCTTCCACCATTCTCTTGA. 
Western blot
The procedure was conducted as previously described [24] . The total protein of cells or liver tissues was extracted using RIPA lysis buffer (Beyotime, Shanghai, China) according to the manufacturer's protocol. Protein concentrations were quantified using the BCA Kit (Beyotime). Protein (30-50 μg) was separated on a 12% sodium dodecyl sulfate-polyacrylamide gel and transferred to polyvinylidene fluoride membranes (Micron Separations, Westborough, MA, USA). Proteins were blocked using a block kit (Beyotime), overnight cultured with gankyrin rabbit IgG antibody (Abcam, Cambridge, MA, USA; catalog no. ab182576; dilution: 1:1000) at 4°C, and with a secondary antibody for 30 min. The immunoreactive proteins were detected using an enhanced chemiluminescence system (Amersham-Pharmacia Biotech, Piscataway, NJ, USA) and subsequent autoradiography.
IHC staining
Each liver section was deparaffinized for 2 h at 65°C, subjected to xylene 3 times for 10 min, and then 100%, 90%, and 70% alcoholic dehydration each for 5 min; the inactivation of peroxidases was achieved using 3% H 2 O 2 for 10 min, washing 3 times for 15 min each time with PBS, antigen retrieval for 20 min at 98°C, and finally blocked for 1 h at 37°C. Sections were cultured with ankyrin rabbit IgG antibody (Abcam; catalog no. ab182576; dilution: 1:250) or GST-P rabbit IgG antibody (Abcam; catalog no. ab138491; dilution: 1:250) overnight at 4°C, with secondary antibodies for 1 h at 37°C, and then diaminobenzidine for 3 min and hematoxylin counterstained for 2 min. Glutathione S-transferase placental form (GST-p) analysis was performed according to our previous study, and the area and number of positive foci in the entire liver section were recorded using a microscope. Gankyrin-positive cells were counted in five random fields to calculate the average positive cell rate.
Statistical analysis SPSS software 19 was used and data shows the mean ± standard deviation. Homoscedasticity was verified when using a parametric test. The independent t-test was used to detect differences between two groups (e.g., differences inGST-p foci or the ratio in the control and MC-LR-treated groups). Oneway analysis of variance (ANOVA) and least significant difference (LSD) analysis were used to detect differences among three or more groups. Correlation between the MC-LR exposure level and gankyrin expression in HCC patients were compared using a Pearson χ2 test and any difference was statistically significant at p < 0.05.
Results
MC-LR promotes proliferation, mobility, and colony formation of L02 cells
Results from the CCK-8 assay showed that MC-LR significantly promoted cell proliferation in a time-and dose-dependent manner (Fig. 1A) . Wound-healing assay results indicated that MC-LR increased cell mobility. L02 cells moved faster when exposed to 100 nM MC-LR compared with 1 and 10 nM MC-LR exposure (Fig. 1B) . Data from the plate colony-formation assay revealed a dose-dependent increase in colony numbers in the MC-LR-exposed group (Fig. 1C) . In comparison with the control, the colony formation in soft agar was significantly elevated in MC-LR-treated cells (Fig. 1D) .
MC-LR induced xenograft formation in nude mice
To demonstrate that MC-LR induced the malignant transformation of L02 cells in vivo, we injected cells treated with MC-LR for 35 passages into the left armpit of nude mice and observed tumor formation for 28 days. Tumor xenografts were observed in mice inoculated with 1, 10, or 100 nM MC-LR-treated L02 cells, whereas no tumor formation was observed in the control group (Fig. 2A) . Increased tumor volumes and weights indicated that MC-LR promoted tumor growth in nude mice (Fig. 2B, 2C) 
Gankyrin expression gradually increased in MC-LR-transformed L02 cells
L02 cells exposed to 1, 10, or 100 nM MC-LR for 5, 15, 25, or 35 passages were tested for gankyrin expression. qRT-PCR analysis revealed both a time-and dose-dependent enhancement of gankyrin expression in MC-LR-transformed L02 cells, and the non-treated group indicated cells without any treatment (Fig. 3A) . Similarly, western blot results indicated that gankyrin protein expression increased in a time-dependent manner in 100 nM MC-LR-treated cells (Fig. 3B) . In addition, immunohistochemical staining showed that gankyrin expression in xenografts of nude mice increased dose-dependently (Fig. 3C) . These results suggest that gankyrin expression gradually increased during the process of MC-LR inducing the malignant transformation of L02 cells.
Silencing gankyrin restrained the MC-LR carcinogenic effect on L02 cells
qRT-PCR and western blot demonstrated the inhibition of gankyrin in transformed cells (Fig. 4A, 4B ). CCK-8 assays showed that silencing gankyrin expression significantly inhibited transformed cell proliferation (Fig. 4C) . Wound-healing assays indicated that the speed of movement toward the wound was significantly lower for the siGankyrin cells than for the siControl cells (Fig. 4D ). As shown in Fig. 4E , colony-formation assays revealed less colony formation in the siGankyrin cells than found in the siControl cells. Taken together, these results reveal that gankyrin inhibition significantly attenuated the malignant transformation of L02 cells induced by MC-LR. 
MC-LR increased neoplastic lesions in SD rats
We also established a rat model via treatment with MC-LR for 35 weeks to confirm that gankyrin expression increased in MC-LR induced hepatocarcinogenesis in vivo. Fig. 5A shows the HE staining, electron microscope, and glutathione S-transferase (GST) IHC staining images, respectively. Liver necrosis and proliferation nodules were observed in the MC-LR group by HE staining. Electron microscope results revealed increased lipid droplets and [25] .
Immunohistochemical staining showed GST-positive foci in the MC-LR-treated group, and the numbers and areas in the liver of each rat were quantified, as shown in Fig. 5B , indicating a time-dependent increase of GST by MC-LR.
Gankyrin expression was up-regulated in MC-LR induced liver neoplastic lesions in SD rats
We evaluated the dynamic changes of gankyrin in SD rats exposed to MC-LR for 10, 20, and 35 weeks, and qRT-PCR showed that gankyrin gene expression significantly increased (Fig. 6A) . Western blot results indicated that gankyrin expression significantly increased during the process of MC-LR induced liver neoplastic lesion formation (Fig. 6B) . Similarly, IHC results revealed a gradual increase of the gankyrin-positive foci in MC-LR-treated rats (Fig. 6C) . These results indicate that gankyrin levels increased in MC-LR induced liver neoplastic lesions of SD rats.
Gankyrin expression levels were elevated in high-MC-LR exposure patients with HCC
To determine the relationship between MC-LR exposure and gankyrin expression, we collected 96 paired tumor tissues and blood samples from patients diagnosed with HCC. We divided them into the low-or high-MC-LR exposure groups according to their median MC-LR exposure level. Basic patient information and MC-LR exposure levels are described in Table 1 . It can be seen that sex, age, and number positive for hepatitis B virus infection were not significantly different between the low-MC-LR and high-MC-LR exposure group, which indicates that the baseline characteristics of these two groups are consistent. A positive, though not significant, correlation was found between the gankyrin expression level and the MC-LR exposure level in tumors (Fig. 7A ). In addition, as shown in Fig. 7B , IHC analysis also showed an increasing trend of gankyrin expression in the MC-LR highexposure patients.
Discussion
This is the first study to demonstrate that MC-LR can induce malignant transformation in normal human liver cells and neoplastic lesion formation in SD rats via the inducement of a key oncogene, gankyrin. Furthermore, it reveals a positive correlation between serum MC-LR levels and gankyrin expression in HCC patients. 
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MC-LR is a potent tumor-promoting agent that contaminates human drinking water. However, whether it can initiate carcinogenesis via inducing key cancer-related oncogenes remains to be elucidated. Only a few studies indicate that MC-LR can malignantly transform normal human cells. For example, colorectal crypt cells are reportedly transformed by microcystin through Akt-MAPK activation [11] . MC-LR induced carcinogenicity in human liver cells WRL-68 accompanied changes to microRNA [10] . In our study, MC-LR promoted proliferation, mobility, and cloning formation of L02 cells. Furthermore, L02 cells exposed to MC-LR for 35 passages induced tumor formation in nude mice. These findings indicate that MC-LR induces malignant transformation in L02 cells.
The constitutive activation of oncogenes and inactivation of anti-oncogenes is typical during cancer development. Oncogenes such as c-fos and c-myc were activated by MC-LR in Wistar rats [26] , whereas MC-LR inactivates p53 to promote cell proliferation via Akt activation [27] . In HepG2 cells, MC-LR significantly de-regulates p53 to interfere with DNA repair [28] . Gankyrin is a key oncogene that contributes to the development of HCC. In this study, both gene and protein expression of gankyrin were found to gradually increase during MC-LR induced transformation of L02 cells. Silencing gankyrin expression in cells inhibited the proliferation, mobility, and colony-forming abilities of MC-LR-transformed L02 cells, which indicates a vital role of gankyrin in MC-LR-transformed cells. In tumor tissue, gankyrin is expressed in both the nucleus and cytoplasm but is predominantly nuclear; however, in non-tumor tissue, it is mainly expressed in the cytoplasm and rarely in the nucleus [29] . In our study, gankyrin was expressed mainly in the nuclei in the liver tumor tissues of HCC patients, while in the livers of MC-LR-treated rats, gankyrin was expressed in the cytoplasm. This indicates that MC-LR does not induce tumor formation in rats. However, we demonstrated that MC-LR can induce neoplastic lesions in rat livers, meaning that the mechanism of MC-LR inducing gankyrin activation requires further study. We infer that increased ROS formation, c-myc expression and Akt-MAPK pathway activation may explain how MC-LR mediates increased gankyrin levels. ROS formation has been reported to contribute to gankyrin activation [30, 31] . In addition, c-myc, as an oncogene induced by MC-LR, was also demonstrated to be a transcriptional activator of gankyrin [32] . MC-LR is reported to transform colorectal crypt cells via Akt-MAPK activation [11] . Furthermore, MAPK activation contributes to increased HURP (hepatoma up-regulated protein), which leads to the accumulation of gankyrin by reducing its ubiquitination [33] .
The evidence supporting tumor initiation by MC-LR in animals is insufficient. However, several two-stage carcinogenesis animal experiments showed that MC-LR enhanced GST expression in diethylnitrosamine (DEN) or aflatoxin-B1 (AFB1) initiated rats, demonstrating the tumor-promoting activity of MC-LR [34] . In this study, MC-LR alone increased the numbers and areas of GST and induced liver neoplastic alterations in SD rats as a result of the up-regulation of gankyrin.
Epidemiological studies, although limited, have indicated increased incidence of liver cancers associated with chronic MC-LR exposure [35, 36] . The relationship between MC-LR internal exposure levels and gankyrin expression levels in human HCC is not clear; however, we found a positive correlation between MC-LR exposure level and gankyrin expression in HCC patients. Gankyrin protein expression in these patients, detected by IHC, agreed with the gene-expression results. However, more samples should be included to confirm a significant relationship between them.
Conclusion
Our results suggest that MC-LR induces malignant transformation in human liver cells and neoplastic lesions in SD rats, which involves an increase in gankyrin levels, indicating that MC-LR can activate oncogenes to induce carcinogenesis. Further, we found a positive correlation between serum MC-LR levels and gankyrin expression in patients with HCC. These findings provide evidence for the potential carcinogenicity of MC-LR and shed light on gankyrin as a potential clinical target for anti-cancer therapy.
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